drugset / Trial / NCT03378674

Remifentanil and Stress Hormones Response

NCT03378674

RandomizedParallel-groupDouble-blindPrevention

Summary

Perioperative adequate analgesia reduces neuroendocrine stress response and postoperative complications. Because opioids are the most effective parenteral drugs to control pain and stress response, in this prospective randomized double-blinded controlled study we supposed that higher dose of remifentanil may reduce stress marker variations compared to lower dose in patients undergoing laparoscopic cholecystectomy.

Timeline

Start
2008-01
Primary completion
2012-07
Completion
2012-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 0.15 ug/kg
Subject Remifentanil Small molecule 0.3 ug/kg

Indications

No indication recorded.